Shandong Weigao Group Medical Polymer Company Limited
Symbol: SHWGF
PNK
0.9575
USDMarktpreis heute
15.4080
P/E-Verhältnis
0.0000
PEG-Verhältnis
4.33B
MRK Kapital
- 0.02%
DIV Rendite
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1140.1 | 1157.2 | 1238.3 | |||||
balance-sheet.row.short-term-investments | 0 | 48.6 | 71.2 | 68.3 | |||||
balance-sheet.row.net-receivables | 0 | 1039.3 | 1016.6 | 963.4 | |||||
balance-sheet.row.inventory | 0 | 351.7 | 332.8 | 279.5 | |||||
balance-sheet.row.other-current-assets | 0 | 95.6 | 93.4 | 69.3 | |||||
balance-sheet.row.total-current-assets | 0 | 2626.7 | 2600 | 2550.5 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 1034 | 1051 | 1055.1 | |||||
balance-sheet.row.goodwill | 0 | 525.5 | 523 | 525.2 | |||||
balance-sheet.row.intangible-assets | 0 | 1507.3 | 770.5 | 807.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 5235.1 | 1293.4 | 1332.6 | |||||
balance-sheet.row.long-term-investments | 0 | 309.5 | 316.4 | 346.4 | |||||
balance-sheet.row.tax-assets | 0 | 29.2 | 22.9 | 24.6 | |||||
balance-sheet.row.other-non-current-assets | 0 | -4488.3 | -512.8 | -512.8 | |||||
balance-sheet.row.total-non-current-assets | 0 | 2119.5 | 2171 | 2245.9 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.account-payables | 0 | 163.2 | 207.3 | 203.2 | |||||
balance-sheet.row.short-term-debt | 0 | 449 | 182.4 | 150 | |||||
balance-sheet.row.tax-payables | 0 | 33.8 | 25.7 | 23.6 | |||||
balance-sheet.row.long-term-debt-total | 0 | 210.8 | 488.3 | 542 | |||||
Deferred Revenue Non Current | 0 | 1.4 | 1.1 | 0.5 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 396.8 | 410 | 409.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 286.9 | 538.3 | 668.5 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 14.2 | 15 | 9.1 | |||||
balance-sheet.row.total-liab | 0 | 1355.7 | 1391.3 | 1480.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 64.4 | 65.7 | 71.7 | |||||
balance-sheet.row.retained-earnings | 0 | 2625.8 | 2475.7 | 2381.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 87.6 | 178.7 | 160.6 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 386.7 | 394.2 | 430.3 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 3164.5 | 3114.3 | 3044.1 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.minority-interest | 0 | 217.6 | 255.5 | 257.3 | |||||
balance-sheet.row.total-equity | 0 | 3382.1 | 3369.8 | 3301.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 358.1 | 387.6 | 414.7 | |||||
balance-sheet.row.total-debt | 0 | 674 | 685.6 | 701.1 | |||||
balance-sheet.row.net-debt | 0 | -417.6 | -400.4 | -468.9 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 405.4 | 351.7 | 302.4 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 118.9 | 113 | 102.2 | ||||
cash-flows.row.deferred-income-tax | 0 | -469.7 | -381.9 | -294.9 | ||||
cash-flows.row.stock-based-compensation | 0 | 91.8 | 76.5 | 30.7 | ||||
cash-flows.row.change-in-working-capital | 0 | -158.8 | -38.1 | -30.3 | ||||
cash-flows.row.account-receivables | 0 | -124.1 | -40.2 | -106.1 | ||||
cash-flows.row.inventory | 0 | -80.2 | -27.9 | -37.9 | ||||
cash-flows.row.account-payables | 0 | 64.1 | -11.2 | 84.1 | ||||
cash-flows.row.other-working-capital | 0 | -18.6 | 41.3 | 29.6 | ||||
cash-flows.row.other-non-cash-items | 0 | 341 | 337.5 | 281.5 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.acquisitions-net | 0 | 4.9 | 219.6 | -19.6 | ||||
cash-flows.row.purchases-of-investments | 0 | -247.2 | -5.9 | -27.6 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.1 | 0.6 | 0.1 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | 0.5 | 216.9 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -408.3 | 34.6 | 23.8 | ||||
cash-flows.row.debt-repayment | 0 | -13.9 | -30.5 | -151.3 | ||||
cash-flows.row.common-stock-issued | 0 | -35.2 | 40.4 | 37.5 | ||||
cash-flows.row.common-stock-repurchased | 0 | -5.2 | -11.3 | -1.9 | ||||
cash-flows.row.dividends-paid | 0 | -110.4 | -101 | -101.6 | ||||
cash-flows.row.other-financing-activites | 0 | 40.3 | -176.3 | 10.5 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -124.5 | -278.7 | -206.9 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 96.2 | -54.4 | -57 | ||||
cash-flows.row.net-change-in-cash | 0 | -84 | 251.7 | 263.1 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 1086 | 1170 | 918.3 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1170 | 918.3 | 655.2 | ||||
cash-flows.row.operating-cash-flow | 0 | 328.6 | 458.7 | 391.6 | ||||
cash-flows.row.capital-expenditure | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.free-cash-flow | 0 | 162.4 | 278.5 | 245.6 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1871.6 | 2027.3 | 2041.4 | |||||
income-statement-row.row.cost-of-revenue | 0 | 970.9 | 1005.8 | 942.3 | |||||
income-statement-row.row.gross-profit | 0 | 900.7 | 1021.6 | 1099.1 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.operating-expenses | 0 | 581.1 | 566.3 | 622.9 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1552 | 1572 | 1565.2 | |||||
income-statement-row.row.interest-income | 0 | 235.7 | 26.8 | 22.4 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 128.2 | 118.9 | 113 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 319.6 | 455.3 | 476.1 | |||||
income-statement-row.row.income-before-tax | 0 | 324.3 | 482.7 | 434 | |||||
income-statement-row.row.income-tax-expense | 0 | 43.5 | 63.2 | 64.9 | |||||
income-statement-row.row.net-income | 0 | 283.2 | 405.4 | 351.7 |
Häufig gestellte Frage
Wie hoch ist die Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Gesamtvermögen?
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Gesamtvermögen ist 4746213417.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.482.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.075.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.152.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.168.
Was ist der Shandong Weigao Group Medical Polymer Company Limited (SHWGF) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 283215434.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 674011810.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 581122121.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.